# A Utility-Based Bayesian Phase I–II Design for Immunotherapy Trials with Progression-Free Survival End Point

> Research article (Journal of the Royal Statistical Society Series C (Applied Statistics), 2018) · cited 21× · AI/ML

**Wikidata**: [openalex:W2803480125](https://www.wikidata.org/wiki/openalex:W2803480125)  
**Source**: https://4ort.xyz/entity/a-utility-based-bayesian-phase-iii-design-for-immunotherapy-trials-with-progression-free-survival-end-point